Takeda Pharmaceutical Co Ltd（TAK）價格預測TAKTakeda Pharmaceutical Co Ltd

Alphio's TAK stock price prediction model matches the current Takeda Pharmaceutical Co Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $18.58 (+0.84%). The 1-week path is $18.52 (+0.51%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Takeda Pharmaceutical Co Ltd (TAK) is a good buy right now due to its current price of 18.03, which is below the analyst price target of approximately 46.25 USD (converted from 6,900 yen). Additionally, the forward P/E ratio of 11.236 suggests that the stock is reasonably valued compared to its earnings potential. The recent approval of Takeda's ORZEYFUL for narcolepsy treatment is a significant positive catalyst that could enhance future revenue streams. However, investors should be cautious of the net income fluctuations, particularly the recent loss of 368.47 billion JPY in Q4 2026, which indicates volatility in profitability.

Takeda Pharmaceutical Co Ltd (TAK) last closed at $18.43, gaining +1.10%. These facts feed the 1-day and 1-week TAK price prediction above.